INSIGHT
THERMO FISHER SCIENTIFIC HIGH-THROUGHPUT TISSUE PROCESSOR PROVEN TO BE IDEAL FOR STANDARD XYLENE-FREE PROTOCOLS Image © Thermo Fisher Scientific
THERMO FISHER SCIENTIFIC Inc., the world leader in serving science, has announced that its new Thermo Scientific STP 420ES Tissue Processor for high- throughput tissue processing has been independently validated for xylene-free protocols. Scientists at the Newcastle upon Tyne Hospitals NHS Foundation Trust confirmed the successful application of a standard xylene-free protocol on the STP 420ES. The tissue processor delivered quality results using existing protocols, with the exception of the requirement for a lower temperature of 65°C, not 85°C, for the initial wax step. For further information, please visit
www.thermoscientific.com/pathology.
“MORE THAN A millennium before Swiss microbiologist Herman Fol discovered the penetration of a spermatozoon into an ovum and proved its essential role in fertilization, Islam understood the concept of sperm-egg fertilization,” said Professor Gerald Schatten of the University of Pittsburgh during the Qatar International Conference on Stem Cell Science and Policy. However, scientific research
in the region has not only occurred historically, but is also happening now, according to Dr. Hatem A. El-Karanshawy of the Qatar Faculty of Islamic Studies. “Research in stem cells has been carried out for quite some time in Qatar and around the region.” Following on fatwas issued
by the Islamic Jurisprudence Council of the Islamic World League in 1997 and 2003, which approved embryonic stem cell research for therapeutic and scientific research purposes (if they were obtained from permissible sources), the SCH set up Qatar’s National Research Ethics Committee
008 MEDLAB MAGAZINE ISSUE 1 2012
QATAR BOASTS A COMPARATIVE ADVANTAGE IN STEM CELL RESEARCH “Moreover,” added Dr.
to establish a Stem Cell Research Policy. “Research and experiments
in induced pluripotent stem cells and mouse and human embryonic stem cells are being conducted in the Middle East, whether here at Weill Cornell in Qatar, in Saudi Arabia or in Iran,” added Dr. Jeremie A.R. Tabrizi of Weill Cornell Medical College in Qatar. “This is because the ethical issues of stem cell research have been clearly addressed in Islam.” Ethical and regulatory clarity is
what has allowed research in stem cells to flourish in Qatar. “Qatar has one of the most permissive policies on stem cell research,” said President of Research and Development at Qatar Foundation for Education, Science and Community Development Faisal Mohammed Al-Suwaidi. Elaborating further, Dr. Faleh
Mohamed Hussein Ali of the SCH said, “Draft legislation on the protection of human tissue, which includes stem cell research, has been approved by the Executive Committee. Once implemented into law, it would enable the SCH to make recommendations, set regulations
and establish a mandate across institutions that would allow for the standardization of research labs here in Qatar.” Dr. Ali concluded, “This
legislation can be a model for laboratories in the GCC and across the Middle East.”
Tabrizi of Weill Cornell, “the establishment of a collaborative stem cell network throughout the region will lead to greater disease- targeted research, which is not currently possible with individual, private investment initiatives.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44